好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | H132 - Brainstorm—A Competition for the Innovator in All of Us (Innovation Hub)

Monday 04/15/24
04:15 PM - 05:30 PM MDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Innovation)
Jose H. Posas, MD, FAAN, Eric Anderson, MD, PhD, FAAN, Daniel J. Ackerman, MD, FAAN, David A. Evans, MBA, Brad C. Klein, MD, MBA, FAAN, Robin Davis, MD, FAAN, Pearce J. Korb, MD, FAAN, Darin T. Okuda, MD, FAAN
General Neurology
This popular Annual Meeting competition has been revamped with a new format that will have teams working together to brainstorm a solution to a prompt they receive on-site! Participants work with the Innovation Hub workgroup to develop their ideas and have the opportunity to showcase their team's idea on the Innovation Hub Stage. Each team can expect a fast-paced challenge culminating in an esteemed panel of judges selecting the winners who will receive the Grand Prize. To create or join a team, complete the form at: https://forms.gle/VyPcoxrPJ4omX4LWA
No CME available

Program Evaluations

Event Timeline
No timeline events available at this time.
Faculty Disclosures
Jose H. Posas, MD, FAAN Dr. Posas has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Posas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Posas has stock in Dane Health. Dr. Posas has a non-compensated relationship as a Advisor with Dane Health that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Lecturer with Concussion Corner Academy that is relevant to AAN interests or activities.
Eric Anderson, MD, PhD, FAAN Dr. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sindler Law firm, WVU, MayerLLP, KBA attorneys. Dr. Anderson has stock in Synapticure. The institution of Dr. Anderson has received research support from NIH.
Daniel J. Ackerman, MD, FAAN Dr. Ackerman has nothing to disclose.
David A. Evans, MBA Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.
Brad C. Klein, MD, MBA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Robin Davis, MD, FAAN Dr. Davis has nothing to disclose.
Pearce J. Korb, MD, FAAN Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Resources.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.